Welcome to the IKCEST

Transplantation | Vol., Issue. | 2020-11-13 | Pages

Transplantation

Mortality rates in transplant recipients and transplantation candidates in a high prevalence COVID-19 environment.

Game, David   Lucisano, Ga   Motallebzadeh, Reza   Thuraisingham, Raj   Jones, Gareth   Tolley, Hannah   Stojanovic, Jelena   Ahmed, Zubir   Marks, Steve   Popoola, Joyce   Banga, Neal   Khurram, Muhammad A   Ghazanfar, Abbas   Mamode, N   Sran, Kiran   Dor, Frank J M F  
Abstract

BACKGROUND: The risk of COVID-19 infection in transplant recipients is unknown. Patients on dialysis may be exposed to greater risk of infection due to an inability to isolate. Consideration of these competing risks is important before restarting suspended transplant programs. This study compared outcomes in kidney and kidney/pancreas transplant recipients with those on the waiting list, following admission with COVID-19 in a high prevalence region. METHODS: Audit data from all 6 London transplant centres were amalgamated. Demographic and laboratory data were collected and outcomes included mortality, intensive care (ITU) admission and ventilation. Adult patients who had undergone a kidney or kidney/pancreas transplant, and those active on the transplant waiting list at the start of the pandemic were included. RESULTS: 121 transplant recipients (TR) and 52 waiting list patients (WL) were admitted to hospital with COVID-19. 36 TR died (30%), whilst 14 WL patients died (27% p=0.71). There was no difference in rates of admission to ITU or ventilation. 24% of TR required renal replacement therapy, and 12% lost their grafts. Lymphocyte nadir and D-dimer peak showed no difference in those who did and did not die. No other co-morbidities or demographic factors were associated with mortality, except for age (odds ratio of 4.3 [95% CI 1.8 - 10.2] for mortality if aged over 60 years) in TR. CONCLUSIONS: Transplant recipients and waiting list patients have similar mortality rates after hospital admission with COVID-19. Mortality was higher in older transplant recipients. These data should inform decisions about transplantation in the COVID era.

Original Text (This is the original text for your reference.)

Mortality rates in transplant recipients and transplantation candidates in a high prevalence COVID-19 environment.

BACKGROUND: The risk of COVID-19 infection in transplant recipients is unknown. Patients on dialysis may be exposed to greater risk of infection due to an inability to isolate. Consideration of these competing risks is important before restarting suspended transplant programs. This study compared outcomes in kidney and kidney/pancreas transplant recipients with those on the waiting list, following admission with COVID-19 in a high prevalence region. METHODS: Audit data from all 6 London transplant centres were amalgamated. Demographic and laboratory data were collected and outcomes included mortality, intensive care (ITU) admission and ventilation. Adult patients who had undergone a kidney or kidney/pancreas transplant, and those active on the transplant waiting list at the start of the pandemic were included. RESULTS: 121 transplant recipients (TR) and 52 waiting list patients (WL) were admitted to hospital with COVID-19. 36 TR died (30%), whilst 14 WL patients died (27% p=0.71). There was no difference in rates of admission to ITU or ventilation. 24% of TR required renal replacement therapy, and 12% lost their grafts. Lymphocyte nadir and D-dimer peak showed no difference in those who did and did not die. No other co-morbidities or demographic factors were associated with mortality, except for age (odds ratio of 4.3 [95% CI 1.8 - 10.2] for mortality if aged over 60 years) in TR. CONCLUSIONS: Transplant recipients and waiting list patients have similar mortality rates after hospital admission with COVID-19. Mortality was higher in older transplant recipients. These data should inform decisions about transplantation in the COVID era.

+More

Keywords

COVID Audit London ITU

Cite this article
APA

APA

MLA

Chicago

Game, David, Lucisano, Ga, Motallebzadeh, Reza, Thuraisingham, Raj, Jones, Gareth, Tolley, Hannah, Stojanovic, Jelena, Ahmed, Zubir, Marks, Steve, Popoola, Joyce, Banga, Neal, Khurram, Muhammad A, Ghazanfar, Abbas,Mamode, N, Sran, Kiran, Dor, Frank J M F,.Mortality rates in transplant recipients and transplantation candidates in a high prevalence COVID-19 environment.. (),.

Disclaimer: The translated content is provided by third-party translation service providers, and IKCEST shall not assume any responsibility for the accuracy and legality of the content.
Translate engine
Article's language
English
中文
Pусск
Français
Español
العربية
Português
Kikongo
Dutch
kiswahili
هَوُسَ
IsiZulu
Action
Recommended articles

Report

Select your report category*



Reason*



By pressing send, your feedback will be used to improve IKCEST. Your privacy will be protected.

Submit
Cancel